Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Cash from Investing Activities (2017 - 2020)

enVVeno Medical has reported Cash from Investing Activities over the past 4 years, most recently at -$27540.0 for Q4 2020.

  • Quarterly results put Cash from Investing Activities at -$27540.0 for Q4 2020, down 112.55% from a year ago — trailing twelve months through Dec 2020 was -$180291.0 (up 50.45% YoY), and the annual figure for FY2025 was $15.9 million, up 1087.72%.
  • Cash from Investing Activities for Q4 2020 was -$27540.0 at enVVeno Medical, down from -$24965.0 in the prior quarter.
  • Over the last five years, Cash from Investing Activities for NVNO hit a ceiling of $123613.0 in Q3 2017 and a floor of -$177230.0 in Q2 2019.
  • Median Cash from Investing Activities over the past 4 years was -$12957.0 (2019), compared with a mean of -$32328.0.
  • Biggest five-year swings in Cash from Investing Activities: crashed 215.79% in 2019 and later skyrocketed 85.48% in 2020.
  • enVVeno Medical's Cash from Investing Activities stood at $69064.0 in 2017, then tumbled by 105.94% to -$4103.0 in 2018, then crashed by 215.79% to -$12957.0 in 2019, then crashed by 112.55% to -$27540.0 in 2020.
  • The last three reported values for Cash from Investing Activities were -$27540.0 (Q4 2020), -$24965.0 (Q3 2020), and -$122473.0 (Q2 2020) per Business Quant data.